NEW YORK (GenomeWeb) – Helomics has signed an agreement to act as the clinical laboratory for Ariel Precision Medicine's PancreasDx pancreatic disease assay, the Pittsburgh-based companies announced today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.